Covered recipient · General Payments record
MATTHEW BRUCE ROBERSON
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$3,150.41
- Reported across 193 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $338.10 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $130.93 | 7 |
| Tris Pharma Inc | $59.26 | 1 |
| Lilly USA, LLC | $28.45 | 2 |
| Biogen, Inc. | $25.37 | 1 |
| Noven Therapeutics, LLC | $24.01 | 1 |
| ABBVIE INC. | $20.59 | 1 |
| PFIZER INC. | $17.49 | 1 |
| Lundbeck LLC | $16.57 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.59 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105956650 | CMS |
| Biogen, Inc. | $25.37 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104877710 | CMS |
| Lilly USA, LLC | $14.39 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135183573 | CMS |
| Lilly USA, LLC | $14.06 | 12/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135183571 | CMS |
| Lundbeck LLC | $16.57 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145961826 | CMS |
| Noven Therapeutics, LLC | $24.01 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084823419 | CMS |
| Novo Nordisk Inc | $13.06 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096832599 | CMS |
| Novo Nordisk Inc | $19.60 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097384930 | CMS |
| Novo Nordisk Inc | $15.33 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096905517 | CMS |
| Novo Nordisk Inc | $19.05 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096984596 | CMS |
| Novo Nordisk Inc | $20.67 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096566812 | CMS |
| Novo Nordisk Inc | $26.61 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097728209 | CMS |
| Novo Nordisk Inc | $16.61 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097064123 | CMS |
| PFIZER INC. | $17.49 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130885638 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.43 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153764515 | CMS |
| Tris Pharma Inc | $59.26 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147207403 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.